rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study

Conditions: Severe Hemophilia A Interventions: Drug: Factor VIII, recombinant human with Fc fusion (rFVIII-Fc) Sponsors: AryoGen Pharmed Co. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials